



DRUG UTILISATION REVIEW IN POSTOPERATIVEPATIENTS IN OBSTETRICS-GYNAECOLOGY 




Southern Institute of Medical sciences, Department of pharmacy, Mangaldas nagar, Guntur, Andhra Pradesh, India 
Email: madhuriphamrd25@gmail.com  
, SETTIPALLI BALA ADITHYA, KANNA VADIVEL 
Received: 09 Jul 2018 Revised and Accepted: 17 Sep 2018 
ABSTRACT 
Objective: The main objectives of our study include classification, analysis and assessment of all the post-operative drugs present of our study.  
Methods: The current project being a retrospective drug utilization review 50 prescriptions from the post-surgical wards of obstetrics–gynaecology 
and surgical gastroenterology departments were collected and analysed. 
Results: All the data collected was classified, analysed and assessed based on the various factors and the results were people between the age group 
of 41-50 have undergone more number of surgeries 22%. Only 32% of all the prescriptions were found to have poly pharmacy, classification of all 
the prescribed drugs shows that the anti biotics were prescribed in the maximum number i.e. 152doses. Parenteral type of formulation was given in 
high number of doses up to 506 doses. Defined daily doses of all the W. H. O essential drug list medications were done. W. H. O prescribing 
indicators for all the drugs in our study was also calculated.  
Conclusion: Our study concludes that the antibiotic drug therapy was used as prophylaxis to prevent the bacterial infection. 
Keywords: Retrospective study, Drug utilisation review, Poly pharmacy, Defined daily doses, Prescribing indicators, Prophylaxis 




Drug utilization review (DUR) is an authorized, organized, ongoing 
study of prescribing, dispensing and use of different types of 
medication. DUR study involves a complete study of the 
prescriptions and the related drug data. Usually, DUR study goes as 
three different methods as prospective, concurrent and 
retrospective; the prospective method-This method involves the 
evaluation of a prescription and the medications before the drugs 
are dispensed. Concurrent–This is an ongoing study, in this the 
prescriptions are analyzed and monitored during the course of the 
treatment. Retrospective–In this method, the prescriptions are 
analysed after the drugs are dispensed [1]. 
DUR study helps in managing health care systems to assess, 
explain, understand and improve the prescribing, administration 
and use of various drugs. Various sectors of healthcare 
management like health care providers consider the DUR 
program extremely valuable as the results are used to boost the 
more efficient use of drugs [2]. Clinical pharmacists contribute to 
a major role in DUR studies because of their proficiency in the 
field of drug therapy. DUR studies can enhance the quality of 
care not only for patients but also for the entire population by 
optimizing the drug therapy by preventing the use of 
inappropriate drugs, taking measures to minimize or avoid 
adverse drug reactions thus by improving the drug effectiveness 
[3, 4].  
Various synonyms considered for DUR include Medication use 
management, medication use evaluation (MUE) and drug use 
evaluation (DUE) [5]. Since the enforcement of the OBRA 90 
(Omnibus Budget Reconciliation Act of 1990), various states have 
enacted their own regulations which require pharmacists to 
collect medication reviews from all the outpatients. Another 
similar official order was introduced in the Medicare prescription 
drug improvement and modernization act of 2003 as medication 
therapy management (MTM). MTM provides appropriate drug plan 
to sponsors by offering a review and appropriate interventions on 
the drugs prescribed [6, 7]. 
Our present study primarily focuses on the DUR in the postoperative 
patients in the departments of the surgical gastroenterology and the 
gynaecology departments respectively. Our team has come forward 
with the aim to conduct a drug utilization review in postoperative 
patients in the departments of surgical gastroenterology, obstetrics, 
and gynaecology. We have chosen all the postoperative drugs in the 
two departments.  
The main objectives of our study include classifying all the 
postoperative drugs into their respective categories based on their 
classification, route of administration and type of formulation. In 
addition our study includes analysing the pattern of drug use among 
the patients based on the age and gender of the patients, 
polypharmacy assessment, calculation of the Defined daily doses of 
the various drugs as per the World Health Organisation (W. H. O) 
guidelines, calculation of the W. H. O prescribing indicators of the 
respected prescribed drugs as the objectives.  
MATERIALS AND METHODS 
Methods 
The study was conducted at a territory care hospital in the 
departments of the surgical gastroenterology, Obstetrics and 
gynaecology, after the informed consent from the volunteer 
respondents and a valid ethical clearance form from Human ethical 
committee with the reference number IHEC/SIMS/2017/011.  
The retrospective drug utilization review includes volunteer 
post-operative in-patients of both the genders from the 
surgical gastroenterology, obstetrics and gynaecology 
departments from 2016-2018. Pregnant women were excluded 
from our study. 
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Table 1: Age and gender distribution 
Age Male Female Total Percentage 
10-20 3 3 6 12% 
21-30 2 7 9 18% 
31-40 3 7 10 20% 
41-50 2 9 11 22% 
51-60 2 4 6 12% 
>60 4 4 8 16% 
 
Table 2: Polypharmacy assessment 
No. of drugs prescribed Male Female Total Percentage 
<5 11 23 34 68% 
>5 6 10 16 32% 
 
Table 3: Distribution of medication in patients 
S. No. Distribution of drugs  No. of doses Percentages 
1. Antibiotics 152 18.26% 
2. Anti hypertensives 30 3.60% 
3. Antacids 139 16.70% 
4. Anti hyperlipidemics 1 0.12% 
5. Anti protozoals  127 15.26% 
6. Analgesics 105 12.62% 
7. Anti-emetics 92 11.05% 
8. Vitamin supplements 1 0.12% 
9. Anti-fibrinolytics 3 0.36% 
10. Anti-anxiety  2 0.24% 
11. Thyroid drugs 6 0.72% 
12. Laxatives 15 1.80% 
13. Iron supplements 14 1.68% 
14. Sympathomimetics 3 0.36% 
15. Corticosteroids  32 3.84% 
16. Local Anesthetics 6 0.72% 
17. Anti-coagulants 12 1.44% 
18. Anti-histamines 6 0.72% 
19. Muscle relaxants 4 0.48% 
20. Acetyl cholinesterase inhibitors 3 0.36% 
21. Hormones 6 0.72% 
22. Broncho dilators 3 0.36% 
23. Anti-psychotics 4 0.48% 
24. Anti–pyretics 31 3.72% 
25. Enzymes 5 0.60% 
26. Anti-epileptics 4 0.48% 
27. Beta 2 receptor agonist 26 3.125% 
 
Table 4: Distribution of formulation 
Type of formulation No. of doses Percentage 
Parenteral 506 63.01% 
Oral 234 29.14% 
Nebulizer 58 7.22% 
Suppository 2 0.24% 
Topical 3 0.37% 
 
Table 5: Defined daily doses of various drugs 
S. No. ATC code Drug name DDD Route of administration 
1. C01CA07 Dobutamine 0.5g Parenteral 
2. A02BC02 Pantoprazole 40 mg Oral 
Parenteral 
3. A02BC04 Rabeprazole 20 mg Oral 
4. A02BC01 Omeprazole 20 mg Oral 
Parenteral 
5. J01XD01 Metronidazole 1.5g Parenteral 
6. J01DD04  Ceftriaxone 2g Parenteral 
7. N02AX02 Tramadol 0.3g Oral 
Parenteral 
Rectal 
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8. A04AA01 Ondansetron 16 mg Oral 
Rectal 
Parenteral 
9. B01AB01 Heparin 10 TU Parenteral 
10. B01AB04 Dalteparin 2.5 TU Parenteral 
11. J01MA01 Ofloxacin 0.4g Oral 
Parenteral 




13. J01MA06 Norfloxacin 0.8g Oral 
14. J01MA12 Levofloxacin 0.5g Oral  
Parenteral 
15. C09CA07 Telmisartan 40 mg Oral 
16. C08CA01 Amlodipine 5 mg Oral 
17. J01DD13  Cefpodoxime 0.4g Oral 
18. N02BB01 Paracetmol 3g Oral 
19. N06AB05 Paroxetine 20 mg Oral 
20. N03AE01 Clonazepam 8 mg Oral 
Parenteral 
21. M01AB16 Aceclofenac 0.2g Oral 
22. M01AB05 Diclofenac 0.1g Oral 
Parenteral 
Rectal 
23. N02AB03 Fentanyl 0.6 mg Nasal 
Sub lingual 
Trans dermal 
24. C01BB01 Lidocaine 3g Parenteral 
25. B02AA02 Tranexamic acid 2g Oral 
Parenteral 
26. G03AC01 Norethistherone 2.5g Parenteral 
27. A03FA01 Metoclopramide 30 mg Oral 
Parenteral 
Rectal 
28. B03AA07 Ferrous Sulphate 0.2g Oral 
29. B03BB01 Folic acid 0.4 mg Oral 








31. G03DA03 Hydroxy 
progesterone 
10 mg Parenteral 






33. J01XX08 Linezolid 1.2g Oral 
Parenteral 
34. C07AB02 Metoprolol 0.15g Oral 
Parenteral 
35. CO3CA01 Furosemide 40 mg Parenteral 
Oral 
36. C07AG01 Labetalol 0.6g Oral 
Parenteral 
37. J01DD13 Cefpodoxime 0.4g Oral 
38. H02AB09 Hydrocortisone 30 mg Oral 
Parenteral 
39. N05AL07 Levosulpiride 0.4g Oral 
40. C08CA14 Clinidipine 10 mg Oral 
41. H03AA01 Levothyroxine sodium 0.15 mg Oral 
Parenteral 
42. R01AD05 Budesonide 0.2 mg Nasal 
43. R03AC02 Salbutamol 0.8 mg Inhalation Aerosol 
Inhalation Powder 
Inhalation Solution 




Table 6: W. H. O. prescribing indicators 
S. No. Prescribing indicators Number 
1. Total no. of prescriptions analysed 50 
2. Total no. of drugs prescribed 212 
3. Average no. of drugs per prescription 4 
4. Drug prescription by generic names 185 
5. Drugs prescribed from Essential Drug List (EDL) 48 
6. Total no. of prescriptions with Antibiotics 49 
7. Drugs prescribed by brand names 27 
8. Total no. of doses prescribed 803 
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A comprehensive study of all the 50 prescriptions was done for the 
drug classification according to their categories, route of 
administration, age, and sex distribution. Polypharmacy assessment 
and defined daily doses calculation was also conducted for all the 
postoperative drugs in our study, finally the W. H. O prescribing 
parameters were also done. The results showed that the highest 
count of postoperative patients between the ages of 41-50 y was 11. 
Followed by the second highest postoperative 10 patients between 
the ages of 31-40. 9 postoperative patients were within the age 
group of 21-30. Elderly postoperative patients of the age group 
above 60 y were 8. And the postoperative patients of the two 
categories between the age group of 10-20 and 51-60 were in the 
same count of 6 respectively. The gender and age distribution 
results show that the total number of females to undergo surgery 
were more when compared to males. More than 5 drugs per 
prescription on a single day was considered as polypharmacy. Out of 
the 50 prescriptions analysed there were 16 prescriptions reported 
as polypharmacy. All the drugs in the prescriptions were classified 
based on their class. In our study a total of 27 classes of drugs were 
analysed and they were classified according to the number of doses 
of each drug for duration of 3 d. The highest count of doses being the 
anti biotics with 152 doses, making a percentage of 18.26%, antacids 
were dispensed in 139 doses making 61.70%, anti hypertensives 
being 30 doses and 3.60%, anti hyperlipidemics were given a single 
dose making a 0.12%, anti protozoals were given in 127 doses 
making a percentage of 15.26%, analgesics were given in 105 doses 
and a percentage of 12.62%, anti-emetics were given in 92 doses 
making a percentage of 11.05%, vitamin supplements were given at 
one dose making 0.12%, anti-fibrinolytics, acetyl cholinesterase 
inhibitors and broncho dilators were given in 3 doses making a 
percentage of 0.36%,anti-anxiety medications were given in 2 doses 
making a total of 0.24%, thyroid medications were given in 6 doses 
making a percentage of 0.72%, laxatives were prescribed in 15 doses 
which make 1.80%, iron supplements were given in 14 doses 
making a percentage of 1.68%, corticosteroid medications were 
given in 32 doses making a percentage of 3.84%, there were 6 local 
anaesthetics given making a percentage of 0.72%, 12 anti-coagulants 
doses make a percentage of 1.44%, 6 anti-histamine doses make a 
percentage of 0.72%, muscle relaxants were given as 4 doses making 
0.48%, 0.72% of hormones were prescribed under 6 doses, 4 anti–
psychotic drugs were prescribed under 0.48% of all the drugs, 31 
doses of anti pyretics drugs were prescribed making 3.72%, 5 doses 
of enzymes were prescribed making a percentage of 0.60%, 4 doses 
of anti-epileptic drugs were prescribed in 0.48%, 26 doses of beta 2 
receptor agonists fall under 3.125% of all doses prescribed[8,9]. All 
the drugs in the 50 prescriptions were analysed and distributed in to 
different types of the formulations parenterals were given in 506 
doses making 63.01%, oral formulations were given in 234 doses 
making 29.14%, nebulizers were given in 58 doses making 7.22%, 
suppositories were given in 2 doses making 0.24% of all the 
formulations given, topical drugs were given in 3 doses making a 
percentage of 0.37%. Defined daily doses (D. D. D) of the individual 
drug per day was calculated according to the W. H. O guidelines, the 
anatomical therapeutic chemical (ATC) classification
As per the results, it is quite evident that the postoperative female 
patients were more than the postoperative male patients. And in the 
polypharmacy assessment, the prescriptions under the non 
polypharmacy were considerably high. The defined daily doses of 
antibiotics were given in the highest doses among all the category of 
the drugs, almost all the prescriptions contained antibiotic drugs. 
Postoperative microbial infection is the major cause of the mortality 
and morbidity. The sole motive of antibacterial drug usage in 
postoperative patients is to avoid infections and provide prophylaxis. 
As the sterile surgical procedures could only decrease the risk of 
contamination but not completely eliminate bacterial infections. 
Judicious usage of antimicrobial drugs is supremely important as 
injudicious use can lead to severe adverse effects like the antimicrobial 
drug resistance. The practice of using antibacterial drugs for 
prophylaxis has shown to eradicate post-operative infections. By the 
judicious use of antimicrobial drugs, a notable reduction in the 
mortality and morbidity rate could be attained. Therefore, the need for 
antibacterial drug use as prophylaxis is highly accepted. 
 system and the 
route of administration of the respective drugs were mentioned for 
individual drug. The DDD of the drugs were dobutamine 0.5g, 
pantoprazole 40 mg, rabeprazole 20 mg, omeprazole 20 mg, 
metronidazole 1.5 mg, ceftriaxone 2g, tramadol 0.3g, ondansetron 
16 mg, heparin 10TU, dalteparin 2.5TU,ofloxacin 0.4g, ciprofloxacin 
1g oral, 0.5g parenteral, norfloxacin 0.8g, levofloxacin0.5g, 
telmisartan 40 mg, amlodipine 5 mg, cefpodoxime 0.4g, paracetamol 
3g, paroxetine 20 mg, clonazepam 8 mg, aceclofenac 0.2g, diclofenac 
0.1g,fentanyl 0.6 mg,lidocaine 3g, tranexamic acid 2g, 
norethistherone 2.5g, metoclopramide 30 mg, ferrous sulphate 0.2g, 
folic acid 0.4 mg, progesterone 0.3g oral, 5 mg parenteral 0.2g 
rectal,90 mg vaginal, hydroxyl progesterone 10 mg, domperidone 
0.12 g rectal, 30 mg parenteral and oral, linezolid 1.2g, metoprolol 
0.15g, furosemide 40 mg, labetalol 0.6g, cefpodoxime 0.4g, 
hydrocortisone 30 mg, levosulpiride 0.4g, cilnidipine 10 mg, 
levothyroxine sodium 0.15 mg, budesonide 0.2 mg, salbutamol 0.8 
mg, a combination of tramadol and paracetamol 4UD[10] i. e-4 
tablets per day. W. H. O prescribing indicators were calculated for all 
the 50 prescriptions in our study, the total number of drugs 
prescribed were average number of drugs per prescription were 4, 
drugs prescribed by generic names were 27, drugs prescribed by 
essential drug list (EDL) were 48 [11], total number of prescriptions 
with antibiotics were 49, drugs prescribed by brand names were 27, 
the total number of doses prescribed were 803. 
CONCLUSION 
Our DUR study provides a valuable perception about the 
comprehensive pattern of drug use in the postoperative patients in 
the respective departments of surgical gastroenterology, obstetrics, 
and gynaecology. The study is useful in the analysis of all the drugs 
used in the postoperative patients. The study of polypharmacy, 
defined daily doses, W. H. O prescribing indicators aids in the 
optimisation of the drug therapy, it also provides valuable insight to 
the medical practitioners and the other health care providers 
regarding the optimisation of the drug therapy. The study regarding 
the DDD and the antibiotic prophylaxis treatment aids in decreasing 
the mortality and morbidity rate among the postoperative cases. 
Ultimately decreases the health care burden in the society. Thus our 
study concludes that a wide range of antibiotics is utilised to 
improve the rational use of drugs. Regular and more DUR studies 
and drug monitoring are recommended to minimize the harmful 
drug effects and improve drug optimisation. Drug utilization study 
knowledge will enable healthcare providers to render their services 
more efficiently.  
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